Literature DB >> 22451075

Increasing batch-to-batch reproducibility of CHO-cell cultures using a model predictive control approach.

Mathias Aehle1, Kaya Bork, Sebastian Schaepe, Artur Kuprijanov, Rüdiger Horstkorte, Rimvydas Simutis, Andreas Lübbert.   

Abstract

By means of a model predictive control strategy it was possible to ensure a high batch-to-batch reproducibility in animal cell (CHO-cell) suspensions cultured for a recombinant therapeutic protein (EPO) production. The general control objective was derived by identifying an optimal specific growth rate taking productivity, protein quality and process controllability into account. This goal was approached indirectly by controlling the oxygen mass consumed by the cells which is related to specific biomass growth rate and cell concentration profile by manipulating the glutamine feed rate. Process knowledge represented by a classical model was incorporated into the model predictive control algorithm. The controller was employed in several cultivation experiments. During these cultivations, the model parameters were adapted after each sampling event to cope with changes in the process' dynamics. The ability to predict the state variables, particularly for the oxygen consumption, led to only moderate changes in the desired optimal operational trajectories. Hence, nearly identical oxygen consumption profiles, cell and protein titers as well as sialylation patterns were obtained for all cultivation runs.

Entities:  

Year:  2012        PMID: 22451075      PMCID: PMC3488369          DOI: 10.1007/s10616-012-9438-1

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  7 in total

1.  Adaptive, model-based control by the Open-Loop-Feedback-Optimal (OLFO) controller for the effective fed-batch cultivation of hybridoma cells.

Authors:  Björn Frahm; Paul Lane; Hendrik Atzert; Axel Munack; Martin Hoffmann; Volker C Hass; Ralf Pörtner
Journal:  Biotechnol Prog       Date:  2002 Sep-Oct

2.  Increasing batch-to-batch reproducibility of CHO cultures by robust open-loop control.

Authors:  M Aehle; A Kuprijanov; S Schaepe; R Simutis; A Lübbert
Journal:  Cytotechnology       Date:  2010-11-06       Impact factor: 2.058

3.  Erythropoietin production from CHO cells grown by continuous culture in a fluidized-bed bioreactor.

Authors:  M-D Wang; M Yang; N Huzel; M Butler
Journal:  Biotechnol Bioeng       Date:  2002-01-20       Impact factor: 4.530

4.  Adaptive control at low glucose concentration of HEK-293 cell serum-free cultures.

Authors:  P Siegwart; J Côté; K Male; J H Luong; M Perrier; A Kamen
Journal:  Biotechnol Prog       Date:  1999 Jul-Aug

5.  Simple and efficient control of CHO cell cultures.

Authors:  M Aehle; S Schaepe; A Kuprijanov; R Simutis; A Lübbert
Journal:  J Biotechnol       Date:  2011-03-17       Impact factor: 3.307

6.  Variation of stoichiometric ratios and their correlation for monitoring and control of animal cell cultures.

Authors:  A P Zeng; W S Hu; W D Deckwer
Journal:  Biotechnol Prog       Date:  1998 May-Jun

7.  Enhanced sialylation of EPO by overexpression of UDP-GlcNAc 2-epimerase/ManAc kinase containing a sialuria mutation in CHO cells.

Authors:  Kaya Bork; Werner Reutter; Wenke Weidemann; Rüdiger Horstkorte
Journal:  FEBS Lett       Date:  2007-08-03       Impact factor: 4.124

  7 in total
  2 in total

1.  A control strategy to investigate the relationship between specific productivity and high-mannose glycoforms in CHO cells.

Authors:  Dénes Zalai; Helga Hevér; Krisztina Lovász; Dóra Molnár; Patrick Wechselberger; Alexandra Hofer; László Párta; Ákos Putics; Christoph Herwig
Journal:  Appl Microbiol Biotechnol       Date:  2016-02-24       Impact factor: 4.813

2.  A system identification approach for developing model predictive controllers of antibody quality attributes in cell culture processes.

Authors:  Brandon Downey; John Schmitt; Justin Beller; Brian Russell; Anthony Quach; Elizabeth Hermann; David Lyon; Jeffrey Breit
Journal:  Biotechnol Prog       Date:  2017-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.